Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-038985

CEO and President bought 19,925 shares at $1.06 ($21,121)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
TRENARY C RUSSELL III CEO and President 2022-06-21 Purchase +19,925 $1.06 $21,121 54,925 D: show line 1 in the form
Open-market purchases · 19,925 sh · avg $1.06 · $21,121
Loading xslF345X03/doc4.xml…